Cardiovascular and Economic Outcomes After Initiation of Lipid-Lowering Therapy With Atorvastatin vs...
Cardiovascular and Economic Outcomes After Initiation of Lipid-Lowering Therapy With Atorvastatin vs Simvastatin in an Employed Population
About this item
Full title
Author / Creator
Publisher
Rochester, MN: Elsevier Inc
Journal title
Language
English
Formats
Publication information
Publisher
Rochester, MN: Elsevier Inc
Subjects
More information
Scope and Contents
Contents
OBJECTIVE To compare the risk of cardiovascular-related hospitalization, statin adherence, and direct (medical and drug) and indirect (disability and medically related absenteeism) costs in US employees in whom atorvastatin or simvastatin was newly prescribed. PATIENTS AND METHODS Active employees aged 18 to 64 years with a new atorvastatin or simv...
Alternative Titles
Full title
Cardiovascular and Economic Outcomes After Initiation of Lipid-Lowering Therapy With Atorvastatin vs Simvastatin in an Employed Population
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2787392
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2787392
Other Identifiers
ISSN
0025-6196
E-ISSN
1942-5546
DOI
10.4065/mcp.2009.0298
